-
Mashup Score: 1News Profile | HealthXL - 4 year(s) ago
Kuldeep Singh Rajput, the founder of Boston-based Biofourmis, is imagining a future where heart failure patients go home with a prescription, a wearable sensor and an app. Today, a new FDA designation gets the company one step closer to that goal. Founded in 2015, Biofourmis is a digital therapeutics company that develops software to “augment” patient care. So far, the company has raised about…
Source: portal-beta.healthxl.comCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Digital Therapeutics (DTX) | HealthXL - 4 year(s) ago
26 May 2021Digital chatbot Woebot lands FDA breakthrough designation to tackle postpartum depression Digital mental health company Woebot Health has landed FDA Breakthrough Device Designation for its postpartum depression digital therapeutic, WB001. WB001 combines cognitive behavioral therapy and elements of interpersonal psychotherapy with the company’s conversational chatbot, Woebot, to deliver…
Source: portal-beta.healthxl.comCategories: Future of Medicine, Latest HeadlinesTweet-
That's a wrap on season 1 of #DTx! @HealthEugene & @bddol reflect on the lessons learned, guest experts & inspiring stories featured. What will the future of DTx look like? Continue the conversation with Eugene & other experts > https://t.co/JgsCxX8OBd https://t.co/B6kWyIEmuw https://t.co/mvAmXApXXX
-
-
Mashup Score: 0DTx opportunities in SE Asia - 4 year(s) ago
DTx opportunities in SE Asia Shwen Gwee VP/Head of Digital Strategy, Bristol-Myers SquibbLouis Payet VP Business Development , Zuellig Pharma 20 May 2021 | 01:00 PM | Zoom About this Meeting The Digital Therapeutics (DTx) market is expected to grow to USD 14.5 Billion by 2027. Southeast (SE) Asia covers over 670mil people across a range of fast growing markets, and consumers have a high level…
Source: portal-beta.healthxl.comCategories: Future of Medicine, Latest HeadlinesTweet-
#DTx opportunities in SE Asia https://t.co/rNi4Tg0lGD - some good peeps joining on May 20th cc: @martykelly @shwen
-
RT @martykelly: Biofourmis receives FDA breakthrough device designation for heart failure “digital therapy” – https://t.co/oenx4qXDzG